PureTech Health (PRTC) Cash & Current Investments (2019 - 2025)

PureTech Health (PRTC) has 7 years of Cash & Current Investments data on file, last reported at $277.3 million in Q4 2025.

• Cash & Current Investments for Q4 2025 came in at $277.3 million, down 38.92% year-over-year; the trailing twelve-month figure through Dec 2025 was $277.3 million (down 38.92% YoY), and the FY2025 annual result was $277.3 million, down 38.92% from the prior year.
• Cash & Current Investments slipped to $277.3 million in Q4 2025 per PRTC's latest filing, from $319.9 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $500.4 million in Q2 2024 and troughed at $277.3 million in Q4 2025.
• A 5-year average of $384.9 million and a median of $350.1 million in 2022 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments jumped 38.77% in 2024, then tumbled 38.92% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $465.7 million in 2021, then fell by 24.83% to $350.1 million in 2022, then declined by 6.55% to $327.1 million in 2023, then soared by 38.77% to $454.0 million in 2024, then plunged by 38.92% to $277.3 million in 2025.
• Business Quant data shows PRTC's Cash & Current Investments at $277.3 million in Q4 2025, $319.9 million in Q2 2025, and $454.0 million in Q4 2024.